Additionally, survival analysis revealed that NB patients with higher STMN2+ TAM scores would suffer poorer prognosis, demonstrating the unfavorable prognosis role of STMN2+ TAM (Figure 6J). The gene discussed is STMN2; the disease is neuroblastoma.